Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

December 11-12, 2018
The Westin Washington, D.C. City Center,
Washington, D.C.

IMMERSE YOURSELF IN THE LATEST US REGULATORY POLICY AT THIS CRITICAL TIME IN SCIENTIFIC INNOVATION

Connect with FDA, CMS, and CDRH Leaders to Learn How Regulatory Changes Will Impact You, Your Organization, and the Biopharma Industry

Book now to SAVE

Register by November 2 and save $100 off the industry rate!

Join discussions on the regulatory focus Post Mid-Term Elections

Hear Updates from the FDA Offices of:
  • Safety, Efficacy and Post Market Surveillance
  • CDER
  • Office of New Drugs
  • Rare Diseases Program
  • CDRH
A full range of topics to be covered include:
  • Changes in the Political Landscape Impacting Pharma and Bio Regulations
  • Delivering Gene Therapies: A New Era in Medicine
  • The Role of Value Based Reimbursement and Value Based Outcomes 
  • Burden of Proof: Building a Value Framework for Regulatory and Payer Approval
Share perspectives on timely politicized movements:
  • Hear the status of the Biosimilar Action Plan recent effort and template to expedite approval of biosimilars
  • RWE In Drug Approval Process
  • Addressing the Opioid Epidemic
  • Expanded access and Right to Try

FDA/CMS SUMMIT SPEAKER Q&As


We asked our speakers to share their expertise on recent developments in federal drug regulations, industry changes, and the resulting impact on their work.

Hear from the experts about what industry shifts and regulation policies we can expect in the near future and how these will affect the decisions and the way things are done.

Become our event partner